Irinot 40mg Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Irinotecan (40mg)
Overview Irinot 40mg Injection
Oncoirin 40mg Injection treats colorectal cancer by inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects may take weeks or months to manifest, discontinue use only under medical guidance. Common side effects include tiredness, nausea, vomiting, debility, and alopecia. This medication can lower blood cell counts (red and white), increasing infection risk. Report fever, sore throat, or persistent diarrhea immediately. Regular blood work, including blood cell counts, and assessments of cardiac, hepatic, and uric acid levels are necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial agents. Drug interactions are possible; inform your healthcare provider of all medications. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout treatment.
Primary Ingredients of Irinot 40mg Injection
No text provided. Please provide the text you wish to be rephrased.
Uses of Irinot 40mg Injection
Colorectal cancer
Major Benefits of Irinot 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Irinot 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Irinot 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Irinot 40mg Injection works:
Irinotecan 40mg Injection is a chemotherapy agent that targets topoisomerase I, an enzyme crucial for cancer cell DNA replication. By inhibiting this enzyme, the drug impedes cancer cell proliferation, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Irinot 40mg Injection may pose unknown safety risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Irinot 40mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated except in extremely rare, life-threatening circumstances where the potential benefits significantly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Irinot 40mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Irinot 40mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Irinot 40mg Injection in individuals with kidney impairment is likely safe, with existing evidence indicating that dosage modification may be unnecessary. However, medical advice is crucial. This medication is contraindicated for patients undergoing dialysis.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Irinot 40mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Irinot 40mg Injection :
Should you forget a dose of Irinot 40mg Injection, seek advice from your physician.
Facts to Know About Irinot 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Topoisomerase inhibitor |
3,018 People bought this recently